News: AcelRx Pharmaceuticals Inc (ACRX.O)

ACRX.O on Consolidated Issue listed on NASDAQ Global Market

3.47USD
22 May 2015
Change (% chg)

$0.02 (+0.58%)
Prev Close
$3.45
Open
$3.43
Day's High
$3.47
Day's Low
$3.30
Volume
553,758
Avg. Vol
817,228
52-wk High
$11.65
52-wk Low
$2.96

Search Stocks
Select another date:

Tue, May 5 2015

Photo

Wall St. ends lower on weak trade data; investors eye Fed

- U.S. stocks finished sharply lower on Tuesday after a surprisingly wide March U.S. trade deficit raised concerns that the economy shrank in the first quarter. | Video

FDA rejects AcelRx's request for meeting on pain drug device

- AcelRx Pharmaceuticals Inc said a division of the U.S. Food and Drug Administration had rejected the company's request for a meeting to discuss the need for an additional trial of its pain drug device, Zalviso.

FDA rejects AcelRx's request for meeting on pain drug device

May 4 - AcelRx Pharmaceuticals Inc said a division of the U.S. Food and Drug Administration had rejected the company's request for a meeting to discuss the need for an additional trial of its pain drug device, Zalviso.

UPDATE 2-FDA seeks additional trial on AcelRx pain drug-device

* Shares fall as much as 42 pct (Adds comment from analyst note)

FDA asks AcelRx for additional trial on pain drug

March 9 - AcelRx Pharmaceuticals Inc said the U.S. Food and Drug Administrations asked the company to conduct an additional clinical study on its pain drug.

Select another date:
Search Stocks